|
1
|
Shaw AT and Gravallese EM: Mediators of
inflammation and bone remodeling in rheumatic disease. Semin Cell
Dev Biol. 49:2–10. 2016. View Article : Google Scholar :
|
|
2
|
Nagao M, Feinstein TN, Ezura Y, Hayata T,
Notomi T, Saita Y, Hanyu R, Hemmi H, Izu Y, Takeda S, et al:
Sympathetic control of bone mass regulated by osteopontin. Proc
Natl Acad Sci USA. 108:17767–17772. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Florencio-Silva R, Sasso GR, Sasso-Cerri
E, Simoes MJ and Cerri PS: Biology of bone tissue: Structure,
function, and factors that influence bone cells. Biomed Res Int.
2015:4217462015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Komori T: Regulation of osteoblast
differentiation by transcription factors. J Cell Biochem.
99:1233–1239. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Suda T, Takahashi N, Udagawa N, Jimi E,
Gillespie MT and Martin TJ: Modulation of osteoclast
differentiation and function by the new members of the tumor
necrosis factor receptor and ligand families. Endocr Rev.
20:345–357. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Takayanagi H: Osteoimmunology: Shared
mechanisms and crosstalk between the immune and bone systems. Nat
Rev Immunol. 7:292–304. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takayanagi H, Kim S, Koga T, Nishina H,
Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, et al:
Induction and activation of the transcription factor NFATc1 (NFAT2)
integrate RANKL signaling in terminal differentiation of
osteoclasts. Dev Cell. 3:889–901. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim K, Kim JH, Lee J, Jin HM, Lee SH,
Fisher DE, Kook H, Kim KK, Choi Y and Kim N: Nuclear factor of
activated T cells c1 induces osteoclast-associated receptor gene
expression during tumor necrosis factor-related activation-induced
cytokine-mediated osteoclastogenesis. J Biol Chem. 280:35209–35216.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin L, Ni B, Lin H, Zhang M, Li X, Yin X,
Qu C and Ni J: Traditional usages, botany, phytochemistry,
pharmacology and toxicology of Polygonum multiflorum Thunb: A
review. J Ethnopharmacol. 159:158–183. 2015. View Article : Google Scholar
|
|
10
|
Kim MJ, Seo BI, Shin SS and Park JH:
Effect of Polygoni multiflori Radix and cynanchi wilfordii Radix on
prevention of osteoporosis in ovariectomized rats. Kor J Herbol.
19:23–34. 2004.
|
|
11
|
Do YJ, Ku SK, Kim HT, Oh T, Cho YM, Kim
SW, Ryu IS and Lee KW: Antiosteoporotic effects of Polygoni
Multiflori Radix (PMR) in ovariectomized (OVX)-induced osteoporosis
in ddY mice. J Vet Clin. 28:375–386. 2011.
|
|
12
|
Kim JY, Baek JM, Ahn SJ, Cheon YH, Park
SH, Yang M, Choi MK and Oh J: Ethanolic extract of Schizonepeta
tenuifolia attenuates osteoclast formation and activation in vitro
and protects against lipopolysaccharide-induced bone loss in vivo.
BMC Complement Altern Med. 16:3012016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ha H, Shim KS, Kim T, An H, Lee CJ, Lee KJ
and Ma JY: Water extract of Acer tegmentosum reduces bone
destruction by inhibiting osteoclast differentiation and function.
Molecules. 19:3940–3954. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rho TW, Lee SY, Han SY, Kim JH, Lee KH,
Kim DS, Kwak HB and Kim YK: Glycyrrhizae Radix inhibits osteoclast
differentiation by inhibiting c-Fos-dependent NFATc1 expression. Am
J Chin Med. 45:283–298. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods.
25:402–408. 2001. View Article : Google Scholar
|
|
16
|
Sharma-Bhandari A, Park SH, Kim JY, Oh J
and Kim Y: Lysyl oxidase modulates the osteoblast differentiation
of primary mouse calvaria cells. Int J Mol Med. 36:1664–1670. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song J, Jing Z, Hu W, Yu J and Cui X:
α-Linolenic acid inhibits receptor activator of NF-κB ligand
induced (RANKL-induced) osteoclastogenesis and prevents
inflammatory bone loss via downregulation of nuclear
Factor-KappaB-inducible nitric oxide synthases (NF-κB-iNOS)
signaling pathways. Med Sci Monit. 23:5056–5069. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim JY, Park SH, Baek JM, Erkhembaatar M,
Kim MS, Yoon KH, Oh J and Lee MS: Harpagoside inhibits
RANKL-induced osteoclastogenesis via Syk-Btk-PLCγ2-Ca2+
signaling pathway and prevents Inflammation-mediated bone loss. J
Nat Prod. 78:2167–2174. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Feng X: RANKing intracellular signaling in
osteoclasts. IUBMB Life. 57:389–395. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Naylor K and Eastell R: Bone turnover
markers: Use in osteoporosis. Nat Rev Rheumatol. 8:379–389. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hofbauer LC: From bone cell biology to
novel therapies of osteoporosis. Drug Res. 65(Suppl 1): S14–S15.
2015. View Article : Google Scholar
|
|
22
|
Chau DL, Edelman SV and Chandran M:
Osteoporosis and diabetes. Curr Diab Rep. 3:37–42. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nardone V, D'Asta F and Brandi ML:
Pharmacological management of osteogenesis. Clinics. 69:438–446.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Boyce BF and Xing L: Functions of
RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem
Biophys. 473:139–146. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kang MR, Jo SA, Yoon YD, Park KH, Oh SJ,
Yun J, Lee CW, Nam KH, Kim Y, Han SB, et al: Agelasine D suppresses
RANKL-induced osteoclastogenesis via down-regulation of c-Fos,
NFATc1 and NF-kB. Mar Drugs. 12:5643–5656. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kong L, Zhao Q, Wang X, Zhu J, Hao D and
Yang C: Angelica sinensis extract inhibits RANKL-mediated
osteoclastogenesis by down-regulated the expression of NFATc1 in
mouse bone marrow cells. BMC Complement Altern Med. 14:4812014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Asagiri M, Sato K, Usami T, Ochi S,
Nishina H, Yoshida H, Morita I, Wagner EF, Mak TW, Serfling E, et
al: Autoamplification of NFATc1 expression determines its essential
role in bone homeostasis. J Exp Med. 202:1261–1269. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ikeda F, Nishimura R, Matsubara T, Tanaka
S, Inoue J, Reddy SV, Hata K, Yamashita K, Hiraga T, Watanabe T, et
al: Critical roles of c-Jun signaling in regulation of NFAT family
and RANKL-regulated osteoclast differentiation. J Clin Invest.
114:475–484. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang H, Ryu J, Ha J, Chang EJ, Kim HJ,
Kim HM, Kitamura T, Lee ZH and Kim HH: Osteoclast differentiation
requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB
transactivation by RANKL. Cell Death Differ. 13:1879–1891. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Iotsova V, Caamaño J, Loy J, Yang Y, Lewin
A and Bravo R: Osteopetrosis in mice lacking NF-kappaB1 and
NF-kappaB2. Nat Med. 3:1285–1289. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hayden MS and Ghosh S: Signaling to
NF-kappaB. Genes Dev. 18:2195–2224. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Orimo H and Shimada T: The role of
tissue-nonspecific alkaline phosphatase in the phosphate-induced
activation of alkaline phosphatase and mineralization in SaOS-2
human osteoblast-like cells. Mol Cell Biochem. 315:51–60. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Karsenty G: Transcriptional control of
skeletogenesis. Annu Rev Genomics Hum Genet. 9:183–196. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lian JB, Stein GS, Javed A, van Wijnen AJ,
Stein JL, Montecino M, Hassan MQ, Gaur T, Lengner CJ and Young DW:
Networks and hubs for the transcriptional control of
osteoblasto-genesis. Rev Endocr Metab Disord. 7:1–16. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ducy P, Zhang R, Geoffroy V, Ridall AL and
Karsenty G: Osf2/Cbfa1: A transcriptional activator of osteoblast
differentiation. Cell. 89:747–754. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Franceschi RT and Xiao G: Regulation of
the osteoblast-specific transcription factor, Runx2: Responsiveness
to multiple signal transduction pathways. J Cell Biochem.
88:446–454. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cancedda R, Castagnola P, Cancedda FD,
Dozin B and Quarto R: Developmental control of chondrogenesis and
osteogenesis. Int J Dev Biol. 44:707–714. 2000.PubMed/NCBI
|
|
38
|
Komori T, Yagi H, Nomura S, Yamaguchi A,
Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, et al:
Targeted disruption of Cbfa1 results in a complete lack of bone
formation owing to maturational arrest of osteoblasts. Cell.
89:755–764. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Otto F, Thornell AP, Crompton T, Denzel A,
Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen
BR, et al: Cbfa1, a candidate gene for cleidocranial dysplasia
syndrome, is essential for osteoblast differentiation and bone
development. Cell. 89:765–771. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lian JB, Stein GS, Stein JL and van Wijnen
AJ: Osteocalcin gene promoter: Unlocking the secrets for regulation
of osteoblast growth and differentiation. J Cell Biochem Suppl.
30–31:62–72. 1998. View Article : Google Scholar
|
|
41
|
Chen G, Deng C and Li YP: TGF-β and BMP
signaling in osteoblast differentiation and bone formation. Int J
Biol Sci. 8:272–288. 2012. View Article : Google Scholar :
|
|
42
|
Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C,
Komori T, Wozney JM, Kim EG, Choi JY, Ryoo HM and Bae SC: Runx2 is
a common target of transforming growth factor beta1 and bone
morphogenetic protein 2, and cooperation between Runx2 and Smad5
induces osteoblast-specific gene expression in the pluripotent
mesenchymal precursor cell line C2C12. Mol Cell Biol. 20:8783–8792.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Islam S, Hassan F, Tumurkhuu G, Dagvadorj
J, Koide N, Naiki Y, Mori I, Yoshida T and Yokochi T: Bacterial
lipopolysaccharide induces osteoclast formation in RAW 264.7
macrophage cells. Biochem Biophys Res Commun. 360:346–351. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mörmann M, Thederan M, Nackchbandi I,
Giese T, Wagner C and Hänsch GM: Lipopolysaccharides (LPS) induce
the differentiation of human monocytes to osteoclasts in a tumour
necrosis factor (TNF) alpha-dependent manner: A link between
infection and pathological bone resorption. Mol Immunol.
45:3330–3337. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ishihara Y, Nishihara T, Maki E, Noguchi T
and Koga T: Role of interleukin-1 and prostaglandin in in vitro
bone resorption induced by Actinobacillus actinomycetemcomitans
lipopolysaccharide. J Periodontal Res. 26:155–160. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Orcel P, Feuga M, Bielakoff J and De
Vernejoul MC: Local bone injections of LPS and M-CSF increase bone
resorption by different pathways in vivo in rats. Am J Physiol.
264:E391–E397. 1993.PubMed/NCBI
|
|
47
|
Kim JY, Cheon YH, Kwak SC, Baek JM, Yoon
KH, Lee MS and Oh J: Emodin regulates bone remodeling by inhibiting
osteoclas-togenesis and stimulating osteoblast formation. J Bone
Miner Res. 29:1541–1553. 2014. View Article : Google Scholar
|
